Leucemia aguda mieloblástica con reordenamiento de MOZ/CBP

Esther Plensa(Hospital de Mataró), Fuensanta Millá, José‐Tomás Navarro(Universitat Autònoma de Barcelona), Josep‐María Ribera(Universitat Autònoma de Barcelona)

Medicina Clínica

January 1, 2004

10.1016/s0025-7753(04)74338-9

Cited by 0

Related Papers

Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study

|The Lancet Oncology|2014|1.3k

Acute lymphoblastic leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

|Annals of Oncology|2016|457

Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome–positive ALL

|Blood|2016|329

Influence of Pre- and Post-Transplantation Responses on Outcome of Patients With Multiple Myeloma: Sequential Improvement of Response and Achievement of Complete Response Are Associated With Longer Survival

|Journal of Clinical Oncology|2008|282

Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Espanol de Linfomas/Trasplante de Medula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

|Haematologica|2011|215